Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may downregulate OR51B5 expression by inhibiting the activity of NF-κB transcription factor, which could decrease transcriptional activation of OR51B5. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could decrease OR51B5 expression by enhancing the deacetylase activity of sirtuins, leading to chromatin condensation and reduced OR51B5 gene transcription. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein could downregulate OR51B5 expression by inhibiting tyrosine kinase activity, thereby disrupting downstream signaling pathways necessary for OR51B5 gene transcription. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin may decrease OR51B5 expression through the inhibition of phosphorylation pathways, leading to reduced activation of transcription factors for OR51B5. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG might reduce OR51B5 expression by binding to DNA methyltransferases, leading to hypermethylation of the OR51B5 gene promoter and transcriptional silencing. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine might indirectly decrease OR51B5 expression by antagonizing adenosine receptors, which could lead to altered cAMP levels and reduced transcription of OR51B5. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could inhibit OR51B5 expression by binding to its receptors and recruiting co-repressor complexes to the OR51B5 gene promoter, leading to chromatin remodeling and transcriptional repression. | ||||||
Methimazole | 60-56-0 | sc-205747 sc-205747A | 10 g 25 g | $70.00 $112.00 | 4 | |
Methimazole might reduce OR51B5 expression by disrupting thyroid hormone synthesis, which is crucial for the homeostatic regulation of olfactory receptor gene expression, including OR51B5. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole may lead to the downregulation of OR51B5 expression through the inhibition of cytochrome P450 enzymes, altering steroid synthesis and thereby modifying OR51B5 gene expression. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Ellagic acid could decrease OR51B5 expression by binding to and inhibiting the DNA topoisomerase II enzyme, leading to DNA cleavage and potentially reducing OR51B5 transcription. | ||||||